Better Buy: Clovis Oncology vs. Sunesis Pharmaceuticals
Clovis Oncology and Sunesis Pharmaceuticals are facing pivotal catalysts for their experimental cancer drugs. Which company offers the better risk-to-reward ratio?
3 Stocks Tumbling This Month: Clovis Oncology, Hyperion Therapeutics, and Puma Biotechnology
Puma Biotechnology (PBYI), Clovis Oncology (CLVS), and Hyperion Therapeutics (HPTX) all stumbled by more than 10% in June.